YOL114C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YOL114C antibody; HRE202Putative uncharacterized protein YOL114C antibody
Target Names
YOL114C
Uniprot No.

Q&A

What is YOL114C and why would researchers develop antibodies against it?

YOL114C is a yeast gene/protein identifier in Saccharomyces cerevisiae that appears in various genetic databases including RefGene, NCBI-Gene, UniProt, and SWISS-PROT . While specific functions of YOL114C remain under investigation, its study is relevant to understanding fundamental cellular processes in yeast. Researchers develop antibodies against YOL114C to detect, quantify, and study the localization and interactions of this protein. YOL114C may have functional relationships with RabGAP proteins involved in cell growth polarization, similar to the yeast proteins Msb3p and Msb4p that function as Ypt/Rab-specific GTPase-activating proteins .

What are the most reliable detection methods when using YOL114C antibodies?

For reliable detection of YOL114C using antibodies, researchers should consider multiple complementary approaches:

  • Western blotting: Effective for determining protein size and relative abundance

  • Immunofluorescence microscopy: Ideal for localization studies

  • Immunoprecipitation: Useful for studying protein-protein interactions

  • Flow cytometry: Applicable for quantitative analysis in cell populations

Each method requires specific optimization for YOL114C detection. When conducting immunofluorescence, researchers should follow established protocols involving proper fixation, permeabilization, and blocking steps. Incubate cells in blocking solution for 1 hour at room temperature or overnight at 4°C, and when using antibodies raised in mice for staining mouse tissue, incorporate Mouse on Mouse (MOM) blocking reagent at a 1:40 dilution to reduce background .

How should researchers validate the specificity of YOL114C antibodies?

A comprehensive validation approach for YOL114C antibodies should include:

Validation MethodProcedureExpected Outcome
Knockout/knockdown controlsGenerate YOL114C-null yeast strainsAbsence of signal in YOL114C-null samples
Overexpression controlsExpress tagged YOL114CEnhanced signal at expected molecular weight
Cross-reactivity testingTest antibody against human homologuesMinimal cross-reactivity unless intended
Peptide competitionPre-incubate antibody with immunizing peptideReduction/elimination of specific signal
Multiple antibody comparisonUse antibodies targeting different epitopesConsistent localization/detection pattern

For immunostaining validation, dilute primary and secondary antibodies in blocking solution according to manufacturer's suggested ratios. Incubate slides overnight at 4°C with primary antibody, wash three times for five minutes with PBS, and incubate with secondary antibodies diluted in blocking buffer for 1 hour at room temperature in the dark .

What are the optimal conditions for preserving YOL114C epitopes during sample preparation?

The preservation of YOL114C epitopes requires careful consideration of fixation and extraction methods:

For yeast cells containing YOL114C:

  • Fixation options:

    • 4% paraformaldehyde (10-15 minutes at room temperature) preserves most protein structures while maintaining morphology

    • Methanol fixation (-20°C for 10 minutes) may better preserve certain epitopes while extracting lipids

    • Glyoxal fixation (4% in PBS) can provide superior ultrastructure preservation

  • Permeabilization considerations:

    • 0.1-0.5% Triton X-100 for 5-10 minutes for balanced permeabilization

    • 0.1-0.2% Saponin for milder permeabilization that preserves membrane structures

    • Digitonin at 10-50 μg/ml for selective plasma membrane permeabilization

When working with antibodies, keep permeabilization buffer away from hydrophobic barriers to avoid loss of hydrophobicity. If this happens, wash the slide thoroughly with PBS .

How can researchers optimize Western blotting protocols for YOL114C detection?

For optimal Western blot detection of YOL114C:

  • Sample preparation:

    • Extract proteins using yeast-specific lysis buffers containing proper protease inhibitors

    • Use glass bead disruption or enzymatic digestion of cell wall followed by detergent lysis

    • Include phosphatase inhibitors if studying phosphorylation states

  • Gel selection and transfer:

    • Choose gel percentage based on YOL114C size (approximately 10-12% for medium-sized proteins)

    • For transfer, PVDF membranes often provide better retention of yeast proteins

    • Transfer at lower voltage (30V) overnight at 4°C may improve transfer of difficult proteins

  • Blocking optimization:

    • Test both BSA and milk-based blocking solutions (milk may contain bioactive proteins)

    • Consider specialized blocking reagents for problematic antibodies

    • Optimize blocking time (1-2 hours at room temperature or overnight at 4°C)

  • Statistical considerations:

    • Perform at least three biological replicates for quantitative analysis

    • Use appropriate statistical tests (t-test for two group comparisons, ANOVA with Tukey post-hoc tests for multiple groups)

    • Set significance threshold at p < 0.05

How should researchers design experiments to study interactions between YOL114C and potential binding partners?

To investigate YOL114C protein interactions:

  • Co-immunoprecipitation (Co-IP):

    • Use both N- and C-terminal tagged constructs to avoid epitope masking

    • Include appropriate controls (IgG control, non-specific antibody)

    • Validate interactions using reciprocal Co-IPs

  • Proximity ligation assay (PLA):

    • Requires antibodies raised in different species

    • Provides spatial information about interactions

    • Controls should include single antibody samples

  • Yeast two-hybrid screening:

    • Consider membrane-based Y2H systems if YOL114C is membrane-associated

    • Verify interactions with complementary methods

    • Test both full-length and domain constructs

  • Comparative analysis with human homologues:

    • Consider expressing human homologues in yeast mutants lacking YOL114C

    • Assess complementation of function as demonstrated with RN-tre complementing msb3 msb4 double mutant yeast strains

    • Analyze conservation of interaction networks between species

How can researchers utilize YOL114C antibodies to study its role in membrane trafficking pathways?

Given potential connections to RabGAP proteins that regulate vesicular trafficking:

  • Subcellular fractionation combined with immunoblotting:

    • Separate membrane fractions using differential centrifugation

    • Identify YOL114C-enriched fractions using specific antibodies

    • Compare distribution with known trafficking markers

  • Live-cell imaging approaches:

    • Combine YOL114C immunodetection with fluorescently-tagged trafficking markers

    • Consider dual-color time-lapse imaging when using compatible antibodies

    • Analyze colocalization coefficients quantitatively

  • Electron microscopy immunogold labeling:

    • Ultra-structural localization at trafficking organelles

    • Double-labeling with markers of different trafficking compartments

    • Develop specific fixation protocols that preserve both antigenicity and membrane structures

  • Functional trafficking assays:

    • Monitor effects of YOL114C perturbation on marker protein trafficking

    • Combine with temperature-sensitive mutants to analyze conditional phenotypes

    • If YOL114C has RabGAP activity similar to Msb3p and Msb4p, assess changes in specific Rab GTPase activation states

What approaches can be used to study potential post-translational modifications of YOL114C?

To investigate post-translational modifications (PTMs) of YOL114C:

  • Phosphorylation analysis:

    • Use phospho-specific antibodies if available

    • Combine with phosphatase treatments as controls

    • Consider mass spectrometry for unbiased phosphosite mapping

    • Run PhosTag gels to separate phosphorylated from non-phosphorylated forms

  • Ubiquitination studies:

    • Immunoprecipitate YOL114C and probe for ubiquitin

    • Express tagged ubiquitin and analyze YOL114C modification

    • Use proteasome inhibitors to trap ubiquitinated forms

  • Other modification analyses:

    • Investigate SUMOylation, acetylation, methylation using specific antibodies

    • Consider genetic approaches (mutating predicted modification sites)

    • Analyze functional consequences of preventing modifications

  • Quantitative analysis of modifications:

    • Use GraphPad Prism for statistical analysis

    • Present data with standard error bars and individual data points

    • Apply appropriate statistical tests based on data distribution

How can researchers use YOL114C antibodies to investigate evolutionary conservation of function?

To study evolutionary conservation using YOL114C antibodies:

  • Comparative immunodetection:

    • Test YOL114C antibody cross-reactivity with homologous proteins from related species

    • Create alignment tables showing epitope conservation across species

    • Use peptide competition assays to confirm specificity

  • Functional complementation studies:

    • Express YOL114C in other species with mutations in homologous genes

    • Analyze rescue of function using antibodies against both proteins

    • Compare with homologue expression in yeast (e.g., human RN-tre can replace the function of MSB3 and MSB4 genes in yeast, while oncTre210p cannot)

  • Domain-specific antibody applications:

    • Develop antibodies against conserved domains (e.g., TBC domains in RabGAPs)

    • Compare immunolocalization patterns across species

    • Analyze conserved protein-protein interactions

  • Mutational analysis:

    • Study effects of restoring conserved amino acids in mutated domains

    • Similar to how researchers restored two highly conserved amino acids including the catalytic arginine in the onc-Tre210p TBC domain

Why might researchers encounter inconsistent results when using YOL114C antibodies, and how can these issues be resolved?

When encountering inconsistent results with YOL114C antibodies:

  • Antibody-related issues:

    • Lot-to-lot variability: Always record lot numbers and test new lots

    • Antibody degradation: Aliquot antibodies and store properly

    • Specificity problems: Validate using knockout controls

  • Sample preparation inconsistencies:

    • Variability in yeast growth conditions affecting protein expression

    • Inconsistent lysis or extraction efficiency

    • Protein degradation during preparation

  • Technical variations:

    • Buffer composition differences affecting antibody binding

    • Inconsistent blocking or washing steps

    • Variations in incubation times or temperatures

  • Resolution approaches:

    • Standardize all protocols with detailed SOPs

    • Include consistent positive and negative controls

    • Consider using automated systems for critical steps

    • For quantitative experiments, normalize to multiple housekeeping proteins

How should researchers analyze and quantify immunofluorescence data for YOL114C localization studies?

For rigorous quantification of YOL114C localization:

  • Image acquisition settings:

    • Use identical acquisition parameters across all samples

    • Avoid saturated pixels

    • Capture multiple fields and cells for statistical robustness

  • Quantification approaches:

    • Measure mean fluorescence intensity in regions of interest

    • Quantify colocalization with organelle markers using Pearson's or Manders' coefficients

    • Analyze distribution patterns (punctate vs. diffuse)

  • Statistical analysis workflow:

    • Compare multiple groups with a one-way ANOVA and Tukey post hoc tests

    • For non-parametric data, use appropriate non-parametric equivalents

    • Set significance threshold at p < 0.05

    • Present data with clear error bars and individual data points

  • Software recommendations:

    • ImageJ/FIJI for basic quantification

    • CellProfiler for automated analysis of large datasets

    • R or GraphPad Prism for statistical analysis and graphing

What considerations are important when designing antibodies against specific YOL114C domains or mutants?

When designing domain-specific or mutant-specific YOL114C antibodies:

  • Epitope selection considerations:

    • Analyze protein structure predictions to identify accessible regions

    • Choose sequences with low homology to other yeast proteins

    • Target regions conserved between homologues if studying evolutionary relationships

    • For phospho-specific antibodies, ensure surrounding sequences increase specificity

  • Antibody format selection:

    • Polyclonal: Better for initial detection, multiple epitopes

    • Monoclonal: Higher specificity, consistent production

    • Recombinant antibodies: Reproducible, defined sequence

  • Validation for mutant-specific antibodies:

    • Test against both wild-type and mutant proteins

    • Verify lack of cross-reactivity with similar mutations

    • Peptide competition with wild-type and mutant peptides

  • Applications for mutation-specific antibodies:

    • Study specific modifications like phosphorylation

    • Track specific protein conformations

    • Distinguish between wild-type and mutant proteins in heterozygous models

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.